SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022141
Filing Date
2020-02-14
Accepted
2020-02-14 21:32:07
Documents
1
Period of Report
2019-06-12

Document Format Files

Seq Description Document Type Size
1 5 a5.html 5  
1 5 a5.xml 5 13392
  Complete submission text file 0001104659-20-022141.txt   14719
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Issuer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE, 6TH FLOOR NEW YORK NY 10024
Business Address
Hoberman Kenneth (Reporting) CIK: 0001573722 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35619 | Film No.: 20623092